Quality of Life in Ovarian-Cancer Patients Receiving Chemotherapy

Akhter, Tohmina; Pervin, Shahana; Goodman, Annekathryn

doi:10.4236/jct.2020.1111059

Cited by 4 publications

(2 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In line with past research conducted in Bangladesh [ 14 , 50 , 51 ], patients with metastatic cancer reported low HRQOL outcomes in terms of physical, functional, emotional, social, and spiritual well-being. These results might be due to Bangladesh’s limited treatment and palliative-care resources as well as limited medical infrastructure, educated workforce, and service availability (e.g., radiotherapy units, radiation treatment) [ 52 – 54 ].…”

Section: Discussionsupporting

confidence: 84%

Quality of life and its predictors among patients with metastatic cancer in Bangladesh: the APPROACH survey

Rahman,

Mariam,

et al. 2024

BMC Palliat Care

View full text Add to dashboard Cite

Background This study aimed to assess the health-related quality of life (HRQOL) (physical, functional, emotional, social, spiritual) and psychological (anxiety and depression) well-being and their associations with patient characteristics among patients with metastatic cancer in Bangladesh. Methods A convenience sample of 386 Bangladeshi patients with stage IV solid cancers was recruited from a palliative care outpatient department and an inpatient palliative center. Dependent variables included the physical, functional, emotional, social, and overall scores of the Functional Assessment of Cancer Therapy-General (FACT-G) scale, the Functional Assessment of Chronic Illness Therapy-Spiritual Well-being (FACIT-SP) scale, the anxiety, depression, and overall scores of the Hospital Anxiety and Depression (HADS) scale. Linear regressions examined the association between dependent variables and patient characteristics. Results A substantial proportion of Bangladeshi patients reported anxiety (59% of outpatients and 55% of inpatients) and depression (60% of outpatients and 73% of inpatients) symptoms. Generally, greater financial difficulty and symptom burden scores were associated with worse health outcomes. Older patients reported poorer functional and spiritual well-being but better anxiety scores. Females reported worse anxiety and depressive symptoms and physical well-being but better spiritual outcomes. Conclusions Additional efforts must be directed at improving the HRQOL of patients with metastatic cancer in Bangladesh. Furthermore, assistance should be made more accessible to vulnerable groups, including women, the elderly, and those with financial difficulty.

show abstract

Section: Discussionsupporting

confidence: 84%

Quality of life and its predictors among patients with metastatic cancer in Bangladesh: the APPROACH survey

Rahman,

Mariam,

et al. 2024

BMC Palliat Care

View full text Add to dashboard Cite

show abstract

“…However, the cited observation of Mayer et al [ 43 ] seems to be isolated in the light of our and other researchers’ observations. Akhert et al [ 44 ] clearly indicate that the quality of life of patients with ovarian cancer is low [ 44 ].…”

Section: Discussionmentioning

confidence: 99%

The Impact of Surgical Treatment with Adjuvant Chemotherapy for Ovarian Cancer on Disorders in the Urinary System and Quality of Life in Women

Opławski

Grabarek²,

Średnicka

et al. 2022

JCM

View full text Add to dashboard Cite

Ovarian cancer is the fourth-most-common cause of death among all malignant cancers in women in Poland. This study aimed to compare the functioning of the urinary system and quality of life in women in the 12-month period following the completion of surgery or adjuvant treatment for ovarian cancer, with patients who underwent a hysterectomy for non-oncological reasons (control group). The study group consisted of 50 patients diagnosed with stage I–III ovarian cancer. Among 38 patients with type II ovarian cancer (group A), surgery followed by first-line chemotherapy was performed. Within this group of patients, 20 had stage I ovarian cancer, while 18 had stage II ovarian cancer. The study was performed at least 6 months after the final chemotherapy cycle, with no clinical, marker or radiological recurrence determined. On the other hand, in 12 patients with stage I type I ovarian cancer, oncological treatment consisted of only surgery, without the need for adjuvant chemotherapy, due to the low stage of the lesions (group B). In turn, the control group consisted of 50 women who underwent uterine removal for non-oncological reasons (group C). The assessment of quality of life was conducted using the questionnaires: Satisfaction with Life Scale (SWLS); Incontinence Impact Questionnaire, short form (IIQ-7); Urogenital Distress Inventory (UDI-6); and the Sexual Satisfaction Scale for 3, 6, 9, and 12 months after the conclusion of oncological treatment. During the follow-up, a significant reduction in the quality of everyday life and sexual life was noted among patients with ovarian cancer, more pronounced in group B, compared to the control group (p < 0.05). The risk of urinary incontinence is independent of the treatment regimen chosen for ovarian cancer. It is necessary to consider comprehensive psychological care and sexual therapy in patients with ovarian cancer and their families.

show abstract

Factors Predicting the Health Status of Women with Ovarian Cancer During Five Treatment Phases

Yang

Chang

Cheng

et al. 2023

Seminars in Oncology Nursing

View full text Add to dashboard Cite

Quality of Life in Ovarian-Cancer Patients Receiving Chemotherapy

Cited by 4 publications

References 41 publications

Quality of life and its predictors among patients with metastatic cancer in Bangladesh: the APPROACH survey

Quality of life and its predictors among patients with metastatic cancer in Bangladesh: the APPROACH survey

The Impact of Surgical Treatment with Adjuvant Chemotherapy for Ovarian Cancer on Disorders in the Urinary System and Quality of Life in Women

Factors Predicting the Health Status of Women with Ovarian Cancer During Five Treatment Phases

Contact Info

Product

Resources

About